[en] Chick embryo fibroblasts cultivated in vitro and treated with cis-dichlorodiamino platinum (II) have been analysed by cytological and cytochemical methods. Morphological alterations (in the nucleoli, in the chromatin and in the cytoplasm), inhibition of DNA and RNA syntheses and of cell multiplication have been noted. Under some conditions, cells are blocked just before entering into mitosis (G2 block) and can become polyploid. A high degree of cell degeneration has also been observed.
AGGARWAL, S.K. and SODHI, A.; Cytotoxic effects of cis-dichloro-diamine platinum (II) on the mammalian cells in vitro. A fine-structural study. Cytobiologie 7: 366-374 (1973).
CONTI, R.C. DE; TOFTNESS, B.R.; LANGE, R.C., and CREASEY, W.A.; Clinical and pharmacological studies with cis-diaminedichloroplatinum (II). Cancer Res. 33: 1310-1315 (1973).
DREWINKO, B.; BROWN, B.W., and GOTTLIEB, J.A.; The effects of cis-dichloro-diamine platinum (II) on cultured human lymphoma cells and its therapeutic implications. Cancer Res. 33: 3091-3095 (1973).
GALE, G.R.; ROSENBLUM, M.G.; ATKINS, L.M.; WALKER, E.M.; SMITH, A.B., and MEISCHEN, S.J.; Antitumor action of cis-dichlorobis (methylamine) platinum (II). J. natn. Cancer Inst. 51: 1227-1234 (1973).
GIRALDI, T. and TAYLOR, D.M.; The effects of platinum ethylenediamine dichloride on the template activity of DNA. Biochem. Pharmac. 23: 1659-1662 (1974).
GOESSENS, G. and LEPOINT, A.; The fine structure of the nucleolus during interphase and mitosis in Ehrlich tumour cells cultivated in vitro. Expl Cell Res. 87: 63-72 (1974).
HARDER, H.C. and ROSENBERG, B.; Inhibitory effects of antitumour platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Int. J. Cancer 6: 207-216 (1970).
HOWLE, J.A. and GALE, G.R.; Cis-dichloro-diamine platinum (II) persistant and selective inhibition of DNA synthesis in vivo. Biochem. Pharmac. 19: 2757-2762 (1970).
HOWLE, J.A.; THOMPSON, H.S.; STONE, A.E., and GALE, G.R.; Cis-dichloro-diamine platinum (II). Inhibition of nuclei acid synthesis in lymphocytes stimulated with phytohaemagglutinin. Proc. Soc. exp. Biol. Med. 137: 820-825 (1971).
LEONARD, B.J.; ECLESTON, E.; IONES, D.; TODD, P., and WALPOLE, A.; Antileucemic and nephrotoxic properties of platinum compounds. Nature, Lond. 222: 385-386 (1969).
PAERMENTIER, F. DE; BASSLEER, R.; LEPOINT, A.; DESAIVE, C.; GOESSENS, G., and Lhoest-Gauthier, M.P.; Mode of action of amphotericin B on chick embryo fibroblasts and mouse Ehrlich tumour cells. A cytological and cytochemical analysis. J. Cell Sci. 18: 441-454 (1975).
PASCOE, J.M. and ROBERTS, J.J.; Interaction between mammalian DNA and inorganic platinum compounds (II). Biochem. Pharmac. 23: 1359-1365 (1974).
RECHER, L.; WHITESCARVER, J., and BRIGGS, L.; The fine structure of a nucleolar constituent. J. Ultrastruct Res. 29: 1-14 (1969).
ROBERTS, J.J. and PASCOE, J.M.; Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds. Nature, Lond. 235: 282-284 (1972).
ROSENBERG, B.; VAN CAMP, L.; TROSKO, J.E., and MANSOUR, V.H.; Platinum compounds: a new class of potent antitumour agents. Nature, Lond. 222: 385-386 (1969).
ROSENBERG, B. and VAN CAMP, L.; The successful regression of large solid sarcoma-180 tumours by platinum compounds. Cancer Res. 30: 1799-1802 (1970).
SODHI, A. and AGGARWAL, S.K.; Effects of cis-dichlorodiamine platinum (II) in the regression of sarcoma 180: a fine-structural study. J. natn. Cancer Inst. 53: 85-89 (1974).
TAYLOR, D.M.; IONES, J.D., and ROBINS, A.B.; Metabolism of platinum 14C-ethyl-enediamine dichloride in the rat. Biol. Pharmac. 22: 833-839 (1973).
WOODMAN, R.J.; SIRICA, A.E.; GANG, M.; KLINE, I., and VENDITI, J.M.; The enhanced therapeutic effect of cis-platinum (II) diaminodichloride against L1210 leukemia when combined with cyclophosphamide or l,2-bis(3,5-dioxopiperazine-l-yl)propane or several antitumour agents. Chemotherapy 18: 169-183 (1973).
